Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence? | Zendy

Ivan Petković | Zendy; Slavica Stojnev | Zendy; Miodrag Krstić | Zendy; Ivica Pejčić | Zendy; Svetislav Vrbić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?

Author(s) -

Ivan Petković,

Slavica Stojnev,

Miodrag Krstić,

Ivica Pejčić,

Svetislav Vrbić

Publication year - 2016

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp150425128p

Subject(s) - medicine , mantle cell lymphoma , vincristine , cyclophosphamide , adenocarcinoma , lymphoma , gastroenterology , oncology , urology , pathology , chemotherapy , cancer

Synchronous occurrence of lymphomas and other cancers, mostly carcinomas are well established. The most of cases describe chronic lymphocytic leukemia as the leading lymphoproliferative disease with the tendency towards secondary malignancies development. Mantle cell lymphoma (MCL) has been described in only 2 cases to co-occur with prostate adenocarcinoma (PAC). There are scarce data about the connection between MCL and urology cancers. We presented the first case of synchronous occurrence of MCL and PAC in the same patient in Serbia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research